Biogen’s experimental drug, diranersen, has shown promising results in slowing cognitive decline in a small subset of people with Alzheimer’s, by lowering levels of the brain protein tau, according to results presented at the Alzheimer’s Association International Conference.
Get FREE morning and afternoon BRIEF ROUNDUPS of all the news sent to your email box. All we need is your email address.
Free, easy and secure news from Sentinel Colorado. Never a paywall.
Sign up for our free Sentinel email E-ditions to get the latest news directly in your inbox.
The Sentinel not only cares deeply about bringing our readers accurate and critical news, we insist all of the crucial stories we provide are available for everyone — for free.
Like you, we know how critical accurate and dependable information and facts are in making the best decisions about, well, everything that matters. Factual reporting is crucial to a sound democracy, a solid community and a satisfying life.
So there’s no paywall at SentinelColorado.com. Our print editions are free on stands across the region, and our daily email E-ditions are free just for signing up, to anyone.
But we need your help to carry out this essential mission.
Please help us keep the Sentinel different and still here when you need us, for everyone. Join us now, and thank you.
We'll send a verification code to %EMAIL%.
